Ocular Hypertension (oh) Clinical Trials
2 recruiting trials for Ocular Hypertension (oh). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Ocular Hypertension (oh) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Lumibird Medical (Quantel Medical, Ellex Medical, Optotek) (1), Glaukos Corporation (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Selective Laser Trabeculoplasty (device, 1 trial), followed by Travoprost.
Track Ocular Hypertension (oh) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Transscleral Selective Laser Trabeculoplasty Project
The purpose of this clinical trial is to determine how safe and effective (how well it works) the ELLEX TSLT device is for the treatment of Glaucoma and Ocular Hypertension using...
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Ocular Hypertension (oh), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Ocular Hypertension (oh), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Ocular Hypertension (oh), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.